Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens-Reference-Cited by-同舟云学术

Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens

Published:2014-08-30 Issue:7 Volume:35 Page:417-429
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

An Guohua¹,Liu Wei¹,Katz David A.²,Marek Gerard J.²,Awni Walid¹,Dutta Sandeep¹

Affiliation:

1. Department of Clinical Pharmacology and Pharmacometrics; R&D, AbbVie Inc.; North Waukegan Road North Chicago IL 60064, USA

2. Neuroscience Clinical Development; R&D, AbbVie Inc.; North Waukegan Road North Chicago IL 60064, USA

Funder

AbbVie

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bdd.1912/fullpdf

Reference32 articles.

1. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase;Agarwal;J Biol Chem,1989

2. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-HSD) type 1 pathway;Basu;Diabetes,2004

3. Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action;Seckl;Endocrinology,2001

4. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues;Ricketts;J Clin Endocrinol Metab,1998

5. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension;Uum;Semin Vasc Med,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target‐Mediated Drug Disposition Model;The Journal of Clinical Pharmacology;2024-04-23

2. Population Target-Mediated Pharmacokinetic/Pharmacodynamic Modeling to Evaluate SPI-62 Exposure and Hepatic 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition in Healthy Adults;Clinical Pharmacokinetics;2023-07-15

3. Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice;Antimicrobial Agents and Chemotherapy;2023-05-17

4. A Pharmacometrics Model to Characterize a New Type of Target-Mediated Drug Disposition (TMDD) – Nonlinear Pharmacokinetics of Small-Molecule PF-07059013 Mediated By Its High-capacity Pharmacological Target Hemoglobin With Positive Cooperative Binding;The AAPS Journal;2023-04-13

5. Importance of Target‐Mediated Drug Disposition (TMDD) of Small‐Molecule Compounds and Its Impact on Drug Development—Example of the Class Effect of HSD‐1 Inhibitors;The Journal of Clinical Pharmacology;2022-12-28